Encompass Health Corporation (EHC)
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat
EHC shares fall 8% after Q3 results, as higher costs offset revenue gains, bed expansions and an upbeat 2025 outlook.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Encompass Health Corporation (EHC) Q3 2025 Earnings Call Transcript
Encompass Health Corporation ( EHC ) Q3 2025 Earnings Call October 30, 2025 10:00 AM EDT Company Participants Mark Miller - Senior Vice President of Investor Relations & Strategic Planning Mark Tarr - CEO, President & Director Douglas Coltharp - Executive VP & CFO Patrick Tuer - EVP & Chief Operating Officer Conference Call Participants Joanna Gajuk - BofA Securities, Research Division Pito Chickering - Deutsche Bank AG, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Albert Rice - UBS Investment Bank, Research Division Brian Tanquilut - Jefferies LLC, Research Division Jared Haase - William Blair & Company L.L.C., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2025 Earnings Conference Call.
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.03 per share a year ago.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health Opens First Connecticut Rehab Hospital in Danbury
EHC opens its first Connecticut rehab hospital in Danbury, boosting its nationwide expansion and meeting rising demand for specialized care.
Encompass Health (EHC) Up 8.6% Since Last Earnings Report: Can It Continue?
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
Here is how Encompass Health (EHC) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
